Genmab — December 2020
-
ummeldt = udmeldt
-
-
ASH har altid være en underlig begivenhed rent kursmæssigt. Investorer bruger den ofte som milestone for enten at bygge op eller unloade aktier. Det giver nogle underlige bevægelser i kursen, som f.eks. I dag
-
I gamle dage talte vi decideret om ASH build-up - men det er vist ikke længere en ting
-
Havde helt glemt Limo Chen. Det var næsten heller ikke muligt at forstå hvad han sagde....
-
Data from the APOLLO Study Show Clinically Meaningful Response with
DARZALEX FASPRO
https://www.janssen.com/us/sites/www_janssen_com_usa/files/data_from_the_apollo_study_show_clinically_meaningful_response_with_darzalex_faspro_daratumumab_and_hyaluronidase-fihj_regimen_after_first_or_subsequent_relapse_in_multiple_myeloma.pdf -
J&J guns for quick drug OK in lung cancer niche, taking the first step challenging AstraZeneca in EGFR https://endpts.com/jj-guns-for-quick-drug-ok-in-lung-cancer-niche-taking-the-first-step-challenging-astrazeneca-in-egfr/
-
https://www.fda.gov/news-events/press-announcements/fda-approves-new-therapy-patients-previously-treated-multiple-myeloma Sarclisa klarer sig godt i en lidt sværere gruppe mindst to tidligere behandlinger. Dara sc er dog stadig en stor fordel.
-
Phil Moreau favors DRd for non-ASCT patients
️Best results we have ever seen in this older population and similar to ACST-eligibal patients https://twitter.com/slentzsch/status/1334952754377236480?s=12 -
God morgen.
-
Tusinde tak for info til E L, Solsen og GB.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind